Cell division snapshot
A cell cycle clock consisting of four continuous stages governs cell division (and replication), with each stage controlled by a specific series of protein complexes. Cancer is characterized by the uncontrolled division of cells that have gained genetic mutations that allow them to overcome these controls, therefore resulting in their self-sufficiency.
A cell cycle clock consisting of four continuous stages governs celldivision (and replication), with each stage controlled by a specific seriesof protein complexes. Cancer is characterized by the uncontrolleddivision of cells that have gained genetic mutations that allow them toovercome these controls, therefore resulting in their self-sufficiency.
Scientists from Virginia Polytechnic Institute and State University(Virginia, USA) took a snapshot of a key transition point, the G1/S phase,in the breast cancer cell cycle by performing LC–MS–MS proteomeanalysis on nuclear and cytoplasmic cell fractions. The group positivelyidentified >2700 proteins from the analysis. Subsequent pathwaymapping, functional annotation clustering, and protein interactionnetwork analysis indicated that top scoring protein clusters could have arole in overriding the check-point.
Corresponding author Iuliana Lazar told The Column that at the proteomic level, the data reveals for the first time new relationships between different protein networks that have an essential role in variousbiological processes such as trancription activation and repression,signalling, and cell-cycle control.
Lazar added: “By providing novel insights into the functionalcategories that drive cancer cells into division, the data points to a broadrange of potential therapeutic targets that concurrently affect the cellcycle signalling and transcriptional/translational machinery.”
Reference
1. M.J. Tenga and Iuliana M. Lazar, Proteomics13(1), 48–60 (2013).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Katelynn Perrault Uptmor Receives the 2025 LCGC Emerging Leader in Chromatography Award
Published: November 13th 2024 | Updated: November 13th 2024November 13, 2024 – LCGC International magazine has named Katelynn A. Perrault Uptmor, Assistant Professor of Chemistry at the College of William & Mary, the recipient of the 2025 Emerging Leader in Chromatography Award. This accolade, which highlights exceptional achievements by early-career scientists, celebrates Perrault Uptmor’s pioneering work in chromatography, particularly in the fields of forensic science, odor analysis, and complex volatile organic compounds (VOCs) research.
